Literature DB >> 20686809

Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome.

Takahiro Kanai1, Hirohiko Shiraishi, Takanori Yamagata, Takane Ito, Jun Odaka, Takashi Saito, Jun Aoyagi, Mariko Y Momoi.   

Abstract

BACKGROUND: Various studies reported a higher incidence of allergic disorders, with an overreactivity of type 2 helper T-cell (Th2) immune mechanisms, in children with idiopathic steroid-sensitive nephrotic syndrome (ISSNS). However, Th2 predominance in ISSNS has not been definitively identified. To determine whether Th2 was predominant in children with ISSNS, we used paired samples to measure the type 1 helper T-cell (Th1)/Th2 ratios and serum cytokine levels secreted by Th1 and Th2.
METHODS: We measured the Th1/Th2 ratios and levels of Th1- or Th2-secreted cytokines in paired samples. Fourteen children met the inclusion criteria: (1) ISSNS; (2) selectivity index < 0.1; (3) sera obtained in at least two disease phases; (4) no infection; (5) no immunosuppressants. Two control groups (group B, normal urinalysis; group C, nephrotic syndrome other than ISSNS) were included for cytokine level comparisons. Th1 and Th2 numbers were counted by three-color flow cytometry. Cytokine levels were measured by bead-based assay.
RESULTS: The Th1/Th2 ratio was lower in group A-1 [nephrotic-phase before steroid treatment (STx)] than in groups A-2 (remission-phase with STx) and A-3 (remission-phase without STx). Th2-secreted interleukin-5 (IL-5) levels were higher in group A-1 than in groups A-2 and A-3. There were no differences in IL-5 levels between groups A-1 and C and between groups A-3 and B.
CONCLUSION: Our results suggest that Th2 played a predominant role both in the Th1/Th2 ratio and in the serum IL-5 level in children with ISSNS in the nephrotic phase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686809     DOI: 10.1007/s10157-010-0330-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  22 in total

1.  Atopy, asthma, and the mycobacteria.

Authors:  J M Hopkin
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE).

Authors:  R J Hogg; R J Portman; D Milliner; K V Lemley; A Eddy; J Ingelfinger
Journal:  Pediatrics       Date:  2000-06       Impact factor: 7.124

3.  Suplatast tosilate dimethylsulfonium treatment for steroid-dependent nephrotic syndrome.

Authors:  Yoshiyuki Ohtomo; Shu-Ichiro Fujinaga; Motoshi Hattori
Journal:  Pediatr Int       Date:  2005-04       Impact factor: 1.524

4.  Age and vitamin E-induced changes in gene expression profiles of T cells.

Authors:  Sung Nim Han; Oskar Adolfsson; Cheol-Koo Lee; Tomas A Prolla; Jose Ordovas; Simin Nikbin Meydani
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

5.  Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome.

Authors:  J Stachowski; C Barth; J Michałkiewicz; T Krynicki; T Jarmoliński; D Runowski; M Lewandowska-Stachowiak; M Zaniew; A Warzywoda; E Bortkiewicz; M Dobosz; J Maciejewski; C A Baldamus
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

6.  IL-5 expression and release from human CD34 cells in vitro; ex vivo evidence from cases of asthma and Churg-Strauss syndrome.

Authors:  A Bossios; M Sjöstrand; A-K Dahlborn; K Samitas; C Malmhäll; M Gaga; J Lötvall
Journal:  Allergy       Date:  2009-11-26       Impact factor: 13.146

7.  Steroid-responsive nephrotic syndrome and allergy: immunological studies.

Authors:  S R Meadow; J K Sarsfield; D G Scott; S M Rajah
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

8.  Steroid-responsive and nephrotic syndrome and allergy: clinical studies.

Authors:  S R Meadow; J K Sarsfield
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

Review 9.  A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos E Araya; Clive H Wasserfall; Todd M Brusko; Wei Mu; Mark S Segal; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  24 in total

1.  Apolipoprotein AII levels are associated with the UP/UCr levels in idiopathic steroid-sensitive nephrotic syndrome.

Authors:  Takahiro Kanai; Takanori Yamagata; Takane Ito; Jun Odaka; Takashi Saito; Jun Aoyagi; Mariko Y Momoi
Journal:  Clin Exp Nephrol       Date:  2014-03-15       Impact factor: 2.801

2.  Insulin resistance in children with primary nephrotic syndrome and normal renal function.

Authors:  Jiaping Jin; Bo Jin; Songming Huang; Yanggang Yuan; Guixia Ding; Huaying Bao; Ying Chen; Yuan Han; Fei Zhao; Aihua Zhang
Journal:  Pediatr Nephrol       Date:  2012-05-24       Impact factor: 3.714

3.  Early occurrence of nephrotic syndrome associated with cord blood stem cell transplantation.

Authors:  Kenichiro Miura; Takashi Sekine; Masaru Takamizawa; Hiroshi Terashima; Ayaka Furuya; Katsuyoshi Koh; Junko Takita; Kohmei Ida; Takashi Igarashi
Journal:  Clin Exp Nephrol       Date:  2011-10-12       Impact factor: 2.801

Review 4.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

Review 5.  Rituximab and minimal change nephrotic syndrome: a therapeutic option.

Authors:  Takashi Takei; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2011-05-26       Impact factor: 2.801

Review 6.  Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms.

Authors:  Gabriel Cara-Fuentes; William L Clapp; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2016-07-06       Impact factor: 3.714

7.  Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.

Authors:  Andreas Kronbichler; Paul König; Martin Busch; Gunter Wolf; Gert Mayer; Michael Rudnicki
Journal:  Wien Klin Wochenschr       Date:  2013-04-27       Impact factor: 1.704

8.  The effect of systemic corticosteroids on the innate and adaptive immune system in children with steroid responsive nephrotic syndrome.

Authors:  Hatice Ezgi Baris; Safa Baris; Elif Karakoc-Aydiner; Ibrahim Gokce; Nurdan Yildiz; Dilek Cicekkoku; Ismail Ogulur; Ahmet Ozen; Harika Alpay; Isil Barlan
Journal:  Eur J Pediatr       Date:  2016-01-30       Impact factor: 3.183

9.  Activation of the acute inflammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids.

Authors:  Neus Roca; Cristina Martinez; Elias Jatem; Alvaro Madrid; Mercedes Lopez; Alfons Segarra
Journal:  Clin Kidney J       Date:  2021-03-30

10.  Multidimensional inflammatory and immunological endotypes of idiopathic focal segmental glomerulosclerosis and their association with treatment outcomes.

Authors:  Neus Roca; Alvaro Madrid; Mercedes Lopez; Gloria Fraga; Elias Jatem; Jorge Gonzalez; Cristina Martinez; Alfons Segarra
Journal:  Clin Kidney J       Date:  2020-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.